Litigation

Recent Posts

William A. Ruskin: Preserving The Attorney-Client Privilege For In-House Counsel
Posted on 13 Feb 2014 by William A. Ruskin

By William A. Ruskin Courts impose on corporate entities the burden of demonstrating that communications and documents shared with in-house counsel are protected by the attorney-client privilege. When companies cannot satisfy this burden, courts have... Read More

Federal Vioxx Judge Awards $315.3 Million To Core Attorney Group
Posted on 20 Oct 2010 by Michael Lefkowitz

NEW ORLEANS - (Mealey's) The judge supervising the Vioxx multidistrict litigation on Oct. 19 awarded $315.3 million to the group of attorneys who conducted discovery and other work of benefit to all federal litigants and those participating in the... Read More

3rd Levaquin MDL Bellwether Trial Ends With 3rd Verdict For Johnson & Johnson
Posted on 27 Jan 2012 by Tom Moylan

MINNEAPOLIS - (Mealey's) The third Levaquin multidistrict litigation tendon rupture trial ended Jan. 26 with a defense verdict, defendant Johnson & Johnson's third compared to one plaintiff victory ( Clifford Straka v. Johnson & Johnson... Read More

Jury In 5th Prempro MDL Bellwether Finds Wyeth Didn't Fail To Warn About Cancer
Posted on 21 Oct 2011 by Tom Moylan

JONESBORO, Ark. - (Mealey's) The fifth bellwether trial in the Prempro multidistrict litigation ended in a defense verdict on Oct. 20 in the U.S. District Court for the Eastern District of Arkansas after a jury found that Wyeth did not inadequately... Read More

Defense Verdict Returned In 1st DePuy Pinnacle Hip Bellwether Case
Posted on 24 Oct 2014 by Tom Moylan

DALLAS — (Mealey’s) Jurors in the U.S. District Court for the Northern District of Texas on Oct. 23 returned a defense verdict for DePuy Orthopaedics Inc. and parent company Johnson & Johnson in the first Pinnacle hip multidistrict litigation... Read More

Plaintiff Attorney Likens Oil Spill Defendants To 'Reservoir Dogs'
Posted on 4 Nov 2010 by Gregg Lawson

MIAMI BEACH - Remember the famous Mexican standoff scene in the movie "Reservoir Dogs" where the gang of crooks turn on each other, hold each other at gunpoint and then shoot each other? Plaintiff attorney Scott Summy of Baron & Budd... Read More

Yasmin, Yaz Gallbladder Cases Settled For $24 Million By Bayer; Payouts Are $2,000-$3,000
Posted on 18 Mar 2013 by Tom Moylan

EAST ST. LOUIS, Ill. — (Mealey’s) Bayer HealthCare Pharmaceuticals Inc. will pay $24 million to resolve claims of plaintiffs who allege that they developed gallbladder disease or underwent gallbladder surgery as a result of using Yasmin or... Read More

Entire Nexium MDL Closed After Expert Excluded; Defense Awarded Costs
Posted on 10 Oct 2014 by Tom Moylan

LOS ANGELES — (Mealey’s) The California federal judge overseeing the Nexium bone injury multidistrict litigation on Oct. 8 entered judgment in favor of manufacturer defendant AstraZeneca Pharmaceuticals LP and related entities and against... Read More

Judge Gives Preliminary OK To Settlement In Chinese Drywall Litigation
Posted on 11 Jan 2012 by Christopher Bauer

NEW ORLEANS - (Mealey's) The federal judge in Louisiana presiding over the Chinese drywall multidistrict litigation on Jan. 10 preliminarily approved a settlement that would resolve thousands of claims involving defective drywall manufactured by Knauf... Read More

2nd Levaquin/Tendon Rupture MDL Trial Ends In Defense Verdict
Posted on 20 Jun 2011 by Tom Moylan

MINNEAPOLIS -- The second trial in the Levaquin antibiotic multidistrict litigation ended in a defense verdict June 17 when a jury in the U.S. District Court for the District of Minnesota found that defendant Ortho-McNeil-Janssen Pharmaceuticals Inc.... Read More

Abbott Withdraws Diet Drug Meridia From U.S. Market
Posted on 8 Oct 2010 by Tom Moylan

ABBOTT PARK, Ill. - (Mealey's) After an unfavorable assessment by a Food and Drug Administration expert committee regarding cardiovascular risk, Abbott Laboratories on Oct. 8 agreed with an FDA request to withdraw the weight-loss drug Meridia (sibutramine... Read More

Jury Awards $9B In 1st MDL Actos Bladder Cancer Trial Against Takeda, Eli Lilly
Posted on 8 Apr 2014 by Tom Moylan

LAFAYETTE, La. — (Mealey’s) The first federal court Actos bladder cancer trial ended April 7 in a $9 billion verdict against co-defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. Inc., according to Takeda ( In Re: Actos [Pioglitazone... Read More